Generation of a recombinant rabies virus expressing green fluorescent protein for a virus neutralization antibody assay

다국어 초록 (Multilingual Abstract)

Background: Fluorescent antibody virus neutralization (FAVN) test is a standard assay for quantifying rabies virus-neutralizing antibody (VNA) in serum. However, a safer rabies virus (RABV) should be used in the FAVN assay. There is a need for a new method that is economical and time-saving by eliminating the immunostaining step.
Objectives: We aimed to improve the traditional FAVN method by rescuing and characterizing a new recombinant RABV expressing green fluorescent protein (GFP).
Methods: A new recombinant RABV expressing GFP designated as ERAGS-GFP was rescued using a reverse genetic system. Immuno-fluorescence assay, peroxidase-linked assay, electron microscopy and reverse transcription polymerase chain reaction were performed to confirm the recombinant ERAGS-GFP virus as a RABV expressing the GFP gene. The safety of ERAGS-GFP was evaluated in 4-week-old mice. The rabies VNA titers were measured and compared with conventional FAVN and FAVN-GFP tests using VERO cells.
Results: The virus propagated in VERO cells was confirmed as RABV expressing GFP. The ERAGS-GFP showed the highest titer (108.0 TCID50/mL) in VERO cells at 5 days post-inoculation, and GFP expression persisted until passage 30. The body weight of 4-week-old mice inoculated intracranially with ERAGS-GFP continued to increase and the survival rate was 100%. In 62 dog sera, the FAVN-GFP result was significantly correlated with that of conventional FAVN (r = 0.95).
Conclusions: We constructed ERAGS-GFP, which could replace the challenge virus standard-11 strain used in FAVN test.

참고문헌 (Reference)

1 Servat A, "Tools for rabies serology to monitor the effectiveness of rabies vaccination in domestic and wild carnivores" 125 : 91-94, 2006

2 World Organization of Animal Health (OIE), "Terrestrial animal health code" OIE 570-575, 2019

3 Kasempimolporn S, "Stray dogs in Bangkok, Thailand : rabies virus infection and rabies antibody prevalence" 131 : 137-143, 2008

4 양동근, "Strategies to maintain Korea’s animal rabies non-occurrence status" 대한백신학회 7 (7): 87-92, 2018

5 Have P, "Risk of rabies introduction by noncommercial movement of pets" 131 : 177-185, 2008

6 Hu Q, "Rescue of recombinant peste des petits ruminants virus : creation of a GFP-expressing virus and application in rapid virus neutralization test" 43 (43): 48-, 2012

7 Kim CH, "Rabies, an emerging disease in Korea" 53 (53): 111-115, 2006

8 Li J, "Postexposure treatment with the live-attenuated rabies virus(RV)vaccine TriGAS triggers the clearance of wild-type RV from the Central Nervous System(CNS)through the rapid induction of genes relevant to adaptive immunity in CNS tissues" 86 (86): 3200-3210, 2012

9 Dietzschold B, "Pathogenesis of rabies" 292 : 45-56, 2005

10 Patel AC, "Molecular and immunogenic characterization of BHK-21 cell line adapted CVS-11 strain of rabies virus and future prospect in vaccination strategy" 26 (26): 288-296, 2015

11 "Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. Rabies (Infection with Rabies Virus and Other Lyssaviruses)" OIE

12 Xue X, "Generation of recombinant rabies virus CVS-11expressing eGFP applied to the rapid virus neutralization test" 6 (6): 1578-1589, 2014

13 Kim JH, "Epidemiological characteristics of rabies in South Korea from 1993 to 2001" 157 (157): 53-56, 2005

14 Wera E, "Cost-effectiveness of mass dog vaccination campaigns against rabies in Flores Island, Indonesia" 64 (64): 1918-1928, 2017

15 Ondrejková A, "Comparison of the quantification of rabies antibodies in canine sera" 47 (47): 218-221, 2012

16 Tang HB, "A recombinant rabies virus expressing a phosphoprotein-eGFP fusion is rescued and applied to the rapid virus neutralization antibody assay" 219 : 75-83, 2015

17 Luo J, "A recombinant rabies virus carrying GFP between N and P affects viral transcription in vitro" 52 (52): 379-387, 2016

18 Khawplod P, "A novel rapid fluorescent focus inhibition test for rabies virus using a recombinant rabies virus visualizing a green fluorescent protein" 125 (125): 35-40, 2005

19 Qin S, "A new recombinant rabies virus expressing a green fluorescent protein : a novel and fast approach to quantify virus neutralizing antibodies" 59 : 56-61, 2019

20 Burgado J, "A high throughput neutralization test based on GFP expression by recombinant rabies virus" 12 (12): e0007011-, 2018

21 양동군, "A genetically modified rabies vaccine (ERAGS) induces protective immunity in dogs and cattle" 대한백신학회 6 (6): 128-134, 2017